A Long-term Efficacy and Safety of NTQ5082 Capsules
NCT07177872
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
78
Enrollment
INDUSTRY
Sponsor class
Conditions
Paroxysmal Nocturnal Hemoglobinuria
Interventions
DRUG:
NTQ5082 capsules 200 mg
Sponsor
Nanjing Chia-tai Tianqing Pharmaceutical